APA (7th ed.) Citation

S, G., H, L., S, S., RA, N., MA, R., A, I., . . . MM, H. (2026). Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine. BMC infectious diseases, 26(1), . https://doi.org/10.1186/s12879-026-12634-x

Chicago Style (17th ed.) Citation

S, Gröhn, et al. "Nucleocapsid Protein Enhances Spike- and RBD-specific Humoral and Cellular Immune Responses in Protein-based SARS-CoV-2 Vaccine." BMC Infectious Diseases 26, no. 1 (2026). https://doi.org/10.1186/s12879-026-12634-x.

MLA (9th ed.) Citation

S, Gröhn, et al. "Nucleocapsid Protein Enhances Spike- and RBD-specific Humoral and Cellular Immune Responses in Protein-based SARS-CoV-2 Vaccine." BMC Infectious Diseases, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12879-026-12634-x.